Analysis finds significant variations in national COVID-19 treatment recommendations
National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to ...
Tag: Remdesivir
Proxalutamide shows promise as potential COVID-19 treatment
At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers ...
Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2
In a recent pre-print uploaded to the medRxiv server, researchers inoculated 34 healthy volunteers with a pre-Alpha severe acute respiratory ...
New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems
In a recent study posted to the bioRxiv* preprint server, researchers at Emory University used severe acute respiratory syndrome coronavirus ...
Remdesivir appears to make a big difference in Japanese patients with COVID-19
The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines ...
Review on Panax ginseng therapeutic efficacy for COVID-19-associated neurological diseases
In a recent review published in the Journal of Ginseng Research, researchers discussed the therapeutic potential of Panax ginseng for ...
Antibody drugs are not recommended for patients with covid-19, say WHO experts
The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with covid-19, says a WHO Guideline Development Group of ...
SARS-CoV-2 nucleocapsid antigen levels and patient outcomes
In a recent study published in the Annals of Internal Medicine, researchers assessed the correlation between severe acute respiratory syndrome ...
Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs
In a recent study posted to the bioRxiv* preprint server, researchers introduced a phenotypic screening assay for identifying compounds with ...
Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses
In a recent study posted to the bioRxiv* pre-print server, researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs). ...